Wakefield Man Died After Being Given Trial Drug Treatment

The family of a father-of-two from Wakefield who died last year days after being treated with a trial drug following a heart attack have revealed how they are hoping for answers from an upcoming inquest into his death.

Kitchen and bathroom fitter Tim Hancock died aged 48 at Leeds General Infirmary on November 25th 2016, around a week after he was admitted to the hospital following a heart attack.

After the heart attack Tim underwent surgery for a stent to be fitted and was also administered with a trial blood thinning drug Alteplase. However, shortly afterwards he suffered a brain haemorrhage and following a second bleed on the brain days later, he passed away.

Following his death, Tim’s family instructed specialist medical negligence lawyers at Irwin Mitchell to investigate the care he received and an inquest is now to take place at Wakefield Coroners Court from 11th December and is expected to last for two days.

Margaret Ryan, the solicitor and medical law expert at Irwin Mitchell’s Leeds office is acting for the family.

Expert Opinion

Around a year on from Tim’s death, his loved ones remain understandably devastated and desperate for answers regarding the circumstances regarding his death.

“We are hopeful that the forthcoming inquest will go some way towards clarifying whether Tim’s medical treatment was appropriate and help his loved ones get answers to the many questions they have.” Margaret Ryan - Partner

Tim’s family holds hope that the inquest will deliver them answers regarding the lack of diagnosis of his endocarditis prior to his death. Endocarditis is a rare and potentially fatal infection of the inner lining of the heart.

After Tim’s death, Leeds General Infirmary told the family they would not have given Tim the trial drug, had his endocarditis been diagnosed.

Karen, 47, said: “Tim was a much-loved husband and father and the entire family miss him so much everyday”.

“While nothing will ever bring Tim back, we all still have so many questions regarding how he died and whether a diagnosis of endocarditis would have avoided him being given the trial drug and therefore if he, would still be alive.

“We truly hope that this inquest will help us understand if anymore could have be done to prevent his death.”

Read more about Irwin Mitchell's expertise in handling medical negligence cases.